Skip to content
Companies

MedRhythms

Rhythm-based digital therapy for walking impairments

Raised to date

$3.1M

of $9M offered across 2 Form D filings

Still open
$5.9M
Investors
3
Last filed
Oct 13, 2026

About

MedRhythms, Inc. is a pioneering digital therapeutics company dedicated to transforming healthcare for individuals suffering from neurologic injuries and diseases. By harnessing the intricate link between music and neuroscience, the company focuses on developing innovative therapeutic solutions aimed at addressing mobility challenges and enhancing functional outcomes for affected individuals.

MedRhythms uniquely integrates music therapy with advanced technology to create personalized rehabilitation solutions that address mobility impairments.

Funding

$8M round, first sold Mar 2025$2.9M sold$5.1M still openMar 20252026
Now
  • DebtFiled Oct 13, 2026Form D
    $250K/ $1M
  • DebtFiled Apr 3, 2025Form D
    $2.9M/ $8M

Product

Digital Therapeutic Platform

Rehabilitation Technology

MedRhythms' flagship product is a sophisticated digital therapeutic platform that utilizes patented technology combining music, sensors, and software. It employs the principle of Rhythmic Auditory Stimulation (RAS) to deliver clinically validated treatments that significantly improve walking impairments by retraining motor functions through rhythm-based neural stimulation.

  • Integration of wearable sensors to monitor patient progress
  • Adaptive algorithms for personalized therapy
  • Clinical research-backed efficacy

Built for

Individuals with neurologic injuries or diseases

People on file